Twist Bioscience Corp

Healthcare · Diagnostics & Research

184.00$ +16.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Twist Bioscience Corp (TWST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 672 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TWST
Line item	Q3 16	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	76	–	86	–	–	123	116	164	140	207	187	192	324	408	399	700	677	725	702	786	1,022	980	961	910	854	810	776	733	703	638	614	609	596	644	642	638	676	672
Current Assets	59	–	68	62	–	104	96	147	121	183	160	129	260	345	335	634	608	577	546	385	664	624	596	542	489	446	424	390	372	362	347	345	338	340	333	304	323	321
Cash	29	–	31	-62	–	91	81	66	29	68	47	26	184	208	94	349	399	475	466	192	408	376	379	317	315	307	286	266	243	239	226	221	210	201	183	149	123	117
Cash & Short-Term Investments	–	–	62	62	–	92	81	130	104	162	138	103	230	312	290	587	556	519	478	302	574	528	505	439	388	357	336	311	293	289	276	271	257	251	232	198	172	167
Receivables	0.7	–	2.3	–	–	4.3	5.4	7.0	8.0	12	12	12	15	13	25	25	24	28	29	33	35	41	40	44	48	43	44	37	37	32	35	39	50	50	57	50	64	66
Inventory	1.2	–	1.8	–	–	4.3	6.0	5.6	4.4	5.5	7.3	7.4	11	13	12	13	16	21	32	40	45	43	39	45	40	36	32	31	30	28	24	24	21	26	28	33	34	35
Property, Plant & Equipment	15	–	15	–	–	13	12	14	15	20	21	59	59	59	25	27	32	101	44	137	92	203	214	145	147	141	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	1.1	–	1.1	–	–	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	23	22	84	86	86	86	86	86	86	86	86	86	86	86	86	86	82	82	82	82	82
Intangible Assets	2.3	–	0.9	–	–	0.8	0.7	0.7	0.6	0.6	0.5	0.5	0.4	0.4	0.3	0.3	0.2	19	18	64	62	61	60	58	57	56	54	53	52	15	14	14	14	14	13	13	13	13
Total Liabilities	19	–	219	–	–	26	317	26	25	31	35	89	60	59	63	62	63	115	121	160	158	159	172	164	150	153	153	143	143	147	142	153	156	165	169	182	221	227
Current Liabilities	8.7	–	9.5	–	–	18	19	19	19	25	30	58	30	31	36	37	40	55	63	80	85	93	91	84	72	73	73	65	67	74	71	70	75	87	91	80	120	120
Short-Term Debt	1.4	–	9.2	–	–	1.7	2.5	3.3	3.3	3.3	3.3	12	11	10	9.7	9.8	9.7	9.9	9.8	13	14	14	14	14	13	13	15	15	15	15	15	15	15	16	14	12	10	8.6
Accounts Payable	2.3	–	2.8	–	–	4.5	7.5	6.7	4.5	7.8	9.8	9.1	6.9	6.0	4.8	8.9	8.5	11	15	23	17	21	20	20	13	12	14	9.3	7.7	6.6	1.6	7.5	8.1	12	11	12	15	17
Long-Term Debt	9.8	–	9.2	–	–	7.9	7.2	6.5	5.8	5.1	4.4	3.7	2.9	2.2	1.4	0.6	–	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–
Shareholders' Equity	57	–	-133	67	–	96	-201	139	115	176	152	103	264	349	336	638	614	610	581	626	863	821	789	746	704	658	623	590	560	491	473	456	440	478	473	456	455	446
Retained Earnings	-80	–	-140	–	–	-191	-211	-233	-259	-287	-319	-374	-406	-434	-458	-491	-529	-569	-611	-656	-717	-777	-828	-870	-929	-987	-1,033	-1,076	-1,122	-1,207	-1,242	-1,274	-1,313	-1,292	-1,320	-1,350	-1,394	-1,429
Shares Outstanding	–	19	19	19	19	19	27	27	28	30	33	33	37	42	45	46	49	49	49	50	53	56	56	56	57	57	57	57	58	58	58	59	60	61	60	61	62	62

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings